Ropes & Gray advised Avista Capital Partners and Cosette Pharmaceuticals on the transaction, and Debevoise & Plimpton advised Hamilton Lane. Avista Capital Partners (“Avista”), a leading...
Hamilton Lane’s Acquisition of Equity Interest in Cosette
Hamilton Lane’s $5.6 Billion Closing of Secondary Fund VI
Ropes & Gray represented Hamilton Lane in the deal. Hamilton Lane (Nasdaq: HLNE) announced the closing of Hamilton Lane Secondary Fund VI with $5.6 billion in...
Hamilton Lane’s Launch of a DLT Share Class
BSP with Hamilton Lane on the innovative creation of a new DLT-registered share class. Hamilton Lane has created an innovative share class for its $3.8 billion...
MiddleGround Carbon CV’s Closing at $440 Million
Dechert served as a buy-side legal advisor and Greenberg Traurig served as a sell-side legal advisor to MiddleGround Capital. Debevoise & Plimpton advised Hamilton Lane as...
Hamilton Lane’s $370 Million Impact Fund II Formation
Ropes & Gray represented Hamilton Lane in the fundraising. Hamilton Lane announced the final closing of Hamilton Lane Impact Fund II. This final close brings total...
Hamilton Lane’s $2.1 Billion Direct Equity Fund Closing
Elvinger Hoss Prussen acted as Luxembourg legal counsel to Hamilton Lane. Hamilton Lane announced the final closing of Hamilton Lane Equity Opportunities Fund V (“the Fund”)....
The Jordan Company’s $1.3 Billion Continuation Fund
Latham & Watkins advised TJC. Ropes & Gray advised Hamilton Lane on the deal. The Jordan Company, L.P. (“TJC”) announced the successful closing of The Resolute II...
LC Healthcare Continued Fund I’s $270 Million Fundraising
Gibson Dunn advised Legend Capital, while Ropes & Gray advised Hamilton Lane and Coller Capital on the deal. Legend Capital announced that the firm has closed LC Healthcare...
LC Healthcare Continued Fund I’s $270 Million Fundraising
Gibson Dunn advised Legend Capital, while Ropes & Gray advised Hamilton Lane and Coller Capital on the deal. Legend Capital announced that the firm has closed LC Healthcare...